Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized Temozolomide in Metastatic Melanoma
NCT01328535Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Jan 2011
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in melanoma, sponsored by Mayo Clinic. Started Jan 2011; status: completed.
02
Drugs
temozolomide
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01328535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01328535.